- Home
- RNA vs AZZ Comparison
RNA vs AZZ Comparison
Compare RNA & AZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- AZZ
- Stock Information
- Founded
- RNA 2012
- AZZ 1956
- Country
- RNA United States
- AZZ United States
- Employees
- RNA N/A
- AZZ N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- AZZ Industrial Specialties
- Sector
- RNA Health Care
- AZZ Industrials
- Exchange
- RNA Nasdaq
- AZZ Nasdaq
- Market Cap
- RNA 4.0B
- AZZ 3.3B
- IPO Year
- RNA 2020
- AZZ N/A
- Fundamental
- Price
- RNA $47.00
- AZZ $108.32
- Analyst Decision
- RNA Strong Buy
- AZZ Buy
- Analyst Count
- RNA 17
- AZZ 6
- Target Price
- RNA $69.53
- AZZ $114.50
- AVG Volume (30 Days)
- RNA 3.8M
- AZZ 254.7K
- Earning Date
- RNA 11-06-2025
- AZZ 10-08-2025
- Dividend Yield
- RNA N/A
- AZZ 0.63%
- EPS Growth
- RNA N/A
- AZZ 908.98
- EPS
- RNA N/A
- AZZ 8.62
- Revenue
- RNA $10,729,000.00
- AZZ $1,586,498,000.00
- Revenue This Year
- RNA N/A
- AZZ $6.86
- Revenue Next Year
- RNA $108.74
- AZZ $4.21
- P/E Ratio
- RNA N/A
- AZZ $12.57
- Revenue Growth
- RNA 1.23
- AZZ 1.70
- 52 Week Low
- RNA $21.51
- AZZ $70.90
- 52 Week High
- RNA $56.00
- AZZ $119.95
- Technical
- Relative Strength Index (RSI)
- RNA 59.14
- AZZ 38.30
- Support Level
- RNA $38.94
- AZZ $107.57
- Resistance Level
- RNA $45.00
- AZZ $110.32
- Average True Range (ATR)
- RNA 2.26
- AZZ 2.81
- MACD
- RNA 0.30
- AZZ -0.78
- Stochastic Oscillator
- RNA 96.88
- AZZ 7.25
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of Metal Coatings, Precoat Metals, and Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company generates the majority of its revenue from the United States.